View in EDS

Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension.

Saved in:

Bibliographic Details
Title:	Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension.
Authors:	Ohashi R; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan., Kondo D; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Otake S; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Murata T; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Kimura G; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan.
Source:	Chemical & pharmaceutical bulletin [Chem Pharm Bull (Tokyo)] 2025; Vol. 73 (8), pp. 670-677.
Publication Type:	Journal Article
Journal Info:	Publisher: Pharmaceutical Society of Japan Country of Publication: Japan NLM ID: 0377775 Publication Model: Print Cited Medium: Internet ISSN: 1347-5223 (Electronic) Linking ISSN: 00092363 NLM ISO Abbreviation: Chem Pharm Bull (Tokyo) Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1347-5223
DOI:	10.1248/cpb.c25-00198